Keywords: ro, enter, trials, roche, tat, antagonist, 24-7429

RO 247429 TO ENTER US TRIALS

Article | 02 November 1992

Print This

Roche's TAT antagonist Ro 24-7429 is to enter Phase I/II clinical trials this month with the AIDS Clinical Trial ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in